ºÝºÝߣshows by User: ManishBhatkar / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: ManishBhatkar / Sat, 26 Nov 2016 06:41:18 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: ManishBhatkar Best Practices - Injectable Packaging Lines /ManishBhatkar/best-practices-injectable-packaging-lines westconference-161126064118
In the past couple of years we have seen many companies recalling sterile products, primarily due to the problems related to particulate matter and/ or sterility assurance. These problems are not only a potential threat to the patient health, but also lead to short supply due to contamination, manufacturing problems, or product discontinuation. Sterile dosage forms are vulnerable to both microbial and particulate contamination, which has been traced to glass and packaging materials, problems such as leaching and sorption and moreover the manufacturing/ operating practices. Recently, in an industry workshop I had shared my thoughts, views, experiences and study findings on this topic and I am happy to share the same with you. I hope this will be useful…]]>
In the past couple of years we have seen many companies recalling sterile products, primarily due to the problems related to particulate matter and/ or sterility assurance. These problems are not only a potential threat to the patient health, but also lead to short supply due to contamination, manufacturing problems, or product discontinuation. Sterile dosage forms are vulnerable to both microbial and particulate contamination, which has been traced to glass and packaging materials, problems such as leaching and sorption and moreover the manufacturing/ operating practices. Recently, in an industry workshop I had shared my thoughts, views, experiences and study findings on this topic and I am happy to share the same with you. I hope this will be useful…]]> Sat, 26 Nov 2016 06:41:18 GMT /ManishBhatkar/best-practices-injectable-packaging-lines ManishBhatkar@slideshare.net(ManishBhatkar) Best Practices - Injectable Packaging Lines ManishBhatkar In the past couple of years we have seen many companies recalling sterile products, primarily due to the problems related to particulate matter and/ or sterility assurance. These problems are not only a potential threat to the patient health, but also lead to short supply due to contamination, manufacturing problems, or product discontinuation. Sterile dosage forms are vulnerable to both microbial and particulate contamination, which has been traced to glass and packaging materials, problems such as leaching and sorption and moreover the manufacturing/ operating practices. Recently, in an industry workshop I had shared my thoughts, views, experiences and study findings on this topic and I am happy to share the same with you. I hope this will be useful… <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/westconference-161126064118-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> In the past couple of years we have seen many companies recalling sterile products, primarily due to the problems related to particulate matter and/ or sterility assurance. These problems are not only a potential threat to the patient health, but also lead to short supply due to contamination, manufacturing problems, or product discontinuation. Sterile dosage forms are vulnerable to both microbial and particulate contamination, which has been traced to glass and packaging materials, problems such as leaching and sorption and moreover the manufacturing/ operating practices. Recently, in an industry workshop I had shared my thoughts, views, experiences and study findings on this topic and I am happy to share the same with you. I hope this will be useful…
Best Practices - Injectable Packaging Lines from Manish Bhatkar
]]> 716 3 https://cdn.slidesharecdn.com/ss_thumbnails/westconference-161126064118-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Annex-1 /slideshow/annex1-66013587/66013587 7a6c8010-b97c-45ff-bdcc-257b1a132d24-160914113043
]]>
]]> Wed, 14 Sep 2016 11:30:42 GMT /slideshow/annex1-66013587/66013587 ManishBhatkar@slideshare.net(ManishBhatkar) Annex-1 ManishBhatkar <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/7a6c8010-b97c-45ff-bdcc-257b1a132d24-160914113043-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Annex-1 from Manish Bhatkar
]]> 249 2 https://cdn.slidesharecdn.com/ss_thumbnails/7a6c8010-b97c-45ff-bdcc-257b1a132d24-160914113043-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-ManishBhatkar-48x48.jpg?cb=1677806150 Post-graduate in Pharmacy (M. Pharm), with extensive experience in manufacturing, quality assurance, projects, validations, regulatory affairs, operations, product & process development and operational budget management of medium and small high-tech pharmaceutical businesses. Related areas of key experience and/ or expertise are: · Pharmaceutical Manufacturing and Quality Assurance · Pharmaceutical Product and Process Development · Pharmaceutical Projects and Technology Transfers · Technical Consulting (Pharmaceutical Facilities,Validation & GMP Compliance Projects) · Conducting and handling GMP and Quality Systems Audit · Productivity and Efficiency Improvement · Cost Reduction Progr... https://cdn.slidesharecdn.com/ss_thumbnails/westconference-161126064118-thumbnail.jpg?width=320&height=320&fit=bounds ManishBhatkar/best-practices-injectable-packaging-lines Best Practices - Injec... https://cdn.slidesharecdn.com/ss_thumbnails/7a6c8010-b97c-45ff-bdcc-257b1a132d24-160914113043-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/annex1-66013587/66013587 Annex-1